Jasplakinolide: From Actin Perturbation to Assay Design
2026-08-08
Jasplakinolide is an actin polymerization inducer that can reveal how filament formation, stabilization, and cellular phenotype are connected. This guide translates chemical-genetics logic from a landmark jasmonate study into a rigorous framework for actin cytoskeleton research, antifungal assays, and antiproliferative experiments.
Fluorescein Tyramide for Neural Circuit Translation
2026-08-07
A thought-leadership guide to using tyramide-based fluorescence amplification to strengthen mechanistic studies of early life adversity, oxytocin signaling, and superior colliculus circuitry while preserving translational rigor.
Cannabidiol Attenuates Orofacial Inflammatory Pain via Canna
2026-08-07
This study reveals that cannabidiol (CBD) robustly alleviates both sensory and affective aspects of orofacial inflammatory pain in mice, primarily through modulation of endocannabinoid and serotonergic signaling. The findings advance mechanistic understanding of multidimensional pain management and underscore the translational potential of CBD in treating pain states with emotional comorbidities.
HATU in Modern Peptide Synthesis: Mechanistic Insights and A
2026-08-06
Explore the advanced chemistry of HATU, a premier peptide coupling reagent, with a deep dive into its mechanism, applications, and recent breakthroughs in selective inhibitor synthesis. This article offers a uniquely detailed perspective on HATU's role in peptide synthesis chemistry and drug discovery.
SGC-CBP30: Advanced CREBBP/EP300 Bromodomain Inhibitor Workf
2026-08-06
SGC-CBP30 empowers precise, reproducible inhibition of CREBBP/EP300 bromodomains for dissecting transcriptional coactivator function in cancer biology and epigenetics. This guide translates recent super-enhancer research into actionable protocols and troubleshooting strategies, with special attention to early-stage lung adenocarcinoma models.
L-Glutathione Reduced: Antioxidant Mechanisms and Research U
2026-08-05
L-Glutathione Reduced is a well-characterized endogenous antioxidant tripeptide that plays essential roles in cellular protection, detoxification, and redox regulation. Its utility as a glutathione S-transferase substrate and oxidative stress biomarker is established in cancer and cardiovascular disease research. Rigorous evidence supports its application in modulating redox-sensitive pathways and benchmarking redox homeostasis.
Sulfaphenazole: Applied CYP2C9 Inhibitor for Translational R
2026-08-05
Sulfaphenazole's precision as a CYP2C9 inhibitor empowers researchers to dissect drug metabolism, vascular function, and antimicrobial pathways with confidence. Its low cytotoxicity and robust selectivity make it an indispensable tool for advanced experimental designs across multiple domains.
LACTB Drives Inner Mitochondrial Remodeling to Promote Apopt
2026-08-04
The reference study reveals LACTB as a crucial regulator of apoptosis through direct remodeling of the inner mitochondrial membrane (IMM), facilitating cytochrome c release independently of canonical BCL-2 family pathways. These findings provide new mechanistic insights into mitochondrial apoptotic pathway activation and present LACTB as a potential tumor suppressor target for cancer research.
Cy5-UTP for RNA Labeling: Protocols, Applications, and Tips
2026-08-04
Cy5-UTP (Cyanine 5-UTP) revolutionizes RNA labeling with robust fluorescence and workflow efficiency, enabling direct probe visualization and multiplexed analyses. This guide details experimental setups, advanced uses in mRNA therapeutics and FISH, and expert troubleshooting for high-sensitivity results.
AI-Driven Discovery of Senolytics: Insights for Cancer Biolo
2026-08-03
The referenced study pioneers the use of machine learning to identify novel senolytic agents capable of selectively eliminating senescent cells, a critical advance for cancer biology and age-related disease research. The approach demonstrates both cost-efficiency and an expanded chemical search space compared to traditional screening, setting new standards for senolytic discovery.
Dual-Metric In Vitro Evaluation Enhances Cancer Drug Assessm
2026-08-03
Schwartz's dissertation advances the evaluation of anticancer compounds by introducing a dual-metric approach that distinguishes between proliferation arrest and cell death in vitro. This refined framework enables more precise interpretation of drug responses, with significant implications for the study and deployment of PLK1 inhibitors such as BI 2536 in cancer research.
LMO2–LDB1 Interaction Drives AML Progression: Mechanistic In
2026-08-02
This study uncovers the pivotal role of the LMO2/LDB1 protein complex in promoting acute myeloid leukemia (AML) progression by supporting leukemic cell proliferation and survival. The findings highlight the mechanistic basis for targeting LMO2/LDB1 in AML and inform future therapeutic strategies.
NPT1-Mediated Renal Apical Transport of Faropenem and PAH
2026-08-01
This study provides the first molecular evidence that the human inorganic phosphate transporter NPT1 mediates p-aminohippuric acid (PAH) and structurally similar organic anion transport, including faropenem, at the renal apical membrane. These findings refine our understanding of renal drug secretion and have key implications for modeling antibiotic pharmacokinetics in resistance studies.
Tioconazole: Antifungal Mechanism & Research Protocol Guide
2026-07-31
Tioconazole is a high-purity antifungal medication that inhibits fungal ergosterol biosynthesis by targeting cytochrome P450 enzymes. Its robust solubility and stability make it a benchmark agent for in vitro antifungal assays and fungal infection models. APExBIO provides Tioconazole with validated purity for advanced research applications.
c-Myc tag Peptide: Mechanistic Leverage and Translational Vi
2026-07-31
Unravel the strategic and mechanistic value of the c-Myc tag Peptide for translational researchers. This article integrates cutting-edge evidence on transcription factor regulation, displacement of c-Myc-tagged fusion proteins, and autophagy-mediated protein stability, providing actionable guidance for experimental design and innovation. APExBIO's reagent is contextually highlighted as a precision tool for advancing both immunoassay workflows and cross-domain research.
458 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page